- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
EAPI
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Euroapi S.A. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
1.01 EUR
3.1%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -32.5% below the Trend Line and sits at 3.5% of its 52-week range. The latest completed week returned 3.1%, after a -19.6% four-week move. The latest news-sentiment score is 44/100.
Setup score
30
out of 100
Latest Close
1.01 EUR
7 Aug 2026
1W Return
3.1%
latest completed week
4W Return
-19.6%
short-term follow-through
12W Return
-30.4%
quarterly tape
Trend Breadth
34.6%
18 of 52 weeks active
Volume Ratio
2.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.1%
Latest completed week; four-week move -19.6%.
Indicator stack
19/45
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
44/100
8 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -32.5% below the Trend Line and sits at 3.5% of its 52-week range. The latest completed week returned 3.1%, after a -19.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1512-week average 0.14
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.15Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -19.6% over four weeks, -30.4% over 12 weeks, and -65.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year18
Trend breadth34.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.09Latest activity-pressure read.
Pressure change-78.5%Four-week change in activity pressure.
Leadership-55.52Latest relative-leadership reading.
RS change-20.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment44/100
Weighted news tone is neutral across 8 relevant articles.
0 positive · 6 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-70.6%Distance below the 52-week high.
13-week volatility7.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2613 weeks finished lower.
Best week+8.0%Week of 8 May.
Worst week-37.5%Week of 6 Mar.
Latest week+3.1%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains7
Flat weeks1
Modest losses7
Sharp losses6
Recent vol7.4%13-week weekly-return volatility.
Base vol8.4%52-week weekly-return volatility.
Up/down split22/29Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -6.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank73 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Drug Manufacturers - Specialty & Generic
4-week rank5 / 5
Group average3.5%
Trend breadth20.0%
Trend20.0%active weekly trend signals
MD60.0%positive activity pressure
RS20.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape32/100
Trend, activity pressure, participation, and risk combine to a 32/100 tape read.
Indicator analysis32/100Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.
Activity pressure 0.15; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment44/100Weighted news tone is neutral across 8 relevant articles.
Euroapi (ENXTPA:EAPI) Stock Tracks Revenue Drop And New Net Debt Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1.01 EUR | 3.1% | 1.50 EUR | 3.59 EUR | 0.09 | -55.52 | 1.5M | Off |
| 31 Jul 2026 | 0.98 EUR | -20.3% | 1.53 EUR | 3.67 EUR | 0.29 | -56.66 | 2.1M | Off |
| 24 Jul 2026 | 1.23 EUR | -3.5% | 1.58 EUR | 3.73 EUR | 0.41 | -45.71 | 361.3K | Off |
| 17 Jul 2026 | 1.27 EUR | 1.4% | 1.61 EUR | 3.80 EUR | 0.44 | -44.55 | 299.1K | Off |
| 10 Jul 2026 | 1.26 EUR | -8.6% | 1.64 EUR | 3.86 EUR | 0.41 | -46.16 | 640.2K | Off |
| 3 Jul 2026 | 1.37 EUR | 4.4% | 1.70 EUR | 3.91 EUR | 0.32 | -43.29 | 79.2K | Off |
| 26 Jun 2026 | 1.32 EUR | 5.1% | 1.76 EUR | 3.97 EUR | 0.22 | -45.83 | 103.7K | Off |
| 19 Jun 2026 | 1.25 EUR | -1.1% | 1.82 EUR | 4.03 EUR | 0.24 | -49.41 | 56.7K | Off |
| 12 Jun 2026 | 1.27 EUR | 0.0% | 1.88 EUR | 4.09 EUR | 0.24 | -49.22 | 121.8K | Off |
| 5 Jun 2026 | 1.27 EUR | -14.9% | 1.94 EUR | 4.15 EUR | 0.24 | -49.33 | 138.9K | Off |
| 29 May 2026 | 1.49 EUR | -0.8% | 2.01 EUR | 4.20 EUR | 0.25 | -41.23 | 740.5K | Off |
| 22 May 2026 | 1.50 EUR | 3.3% | 2.06 EUR | 4.26 EUR | 0.02 | -41.01 | 617.6K | Off |
| 15 May 2026 | 1.45 EUR | -1.9% | 2.12 EUR | 4.31 EUR | -0.32 | -42.30 | 1.1M | Off |
| 8 May 2026 | 1.48 EUR | 8.0% | 2.18 EUR | 4.37 EUR | -0.65 | -42.87 | 1.3M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.